News

A recent study showed donor characteristics can affect the quantity of platelets obtained for FNAIT platelet transfusions.

A recent study showed placenta-related biomarkers may play an important role in predicting FNAIT disease severity.

Researchers have successfully synthesized an antibody against the CD36 platelet antigen, which has potential therapeutic implications for FNAIT.

According to a recent press release, the Australian red cross is assessing the feasibility of non-invasive prenatal testing to detect certain antigens.

A recent literature review highlights the need for more research on blood donor characteristics and their impact on patient outcomes.

Results of a recent analysis showed that the risk for alloimmunization was highest among women in Caucasian populations.

A recent study found that sepsis, genetic mutations and perinatal asphyxia are common causes of severe neonatal thrombocytopenia in China.

A recent study found a link between key DNA markers and type I CD36 deficiency in platelet donors to patients with FNAIT.

Researchers of a recently published review stated more data is needed to confirm the link between ITP and the risk of FNAIT.

A recent study found more data is needed to confirm the link between HPA antigens and the development of autoimmune thrombocytopenia.